并发症和全身类固醇在炎症性肠道疾病中增加肺炎风险:倾向性得分匹配的队列研究
Yong Eun1, Joan Culpepper-Morgan2,3, Abiodun M Akanmode4
1Department of Medicine, NYC Health + Hospitals/Harlem, New York, NY 10037, United States. euny@nychhc.org.
概括
炎症性肠病 (IBD) 患者面临更高的肺炎风险,原因是并发症和全身类固醇,而不是IBD本身. 管理应针对这些因素,并鼓励高风险人群接种疫苗.
科学领域:
- 胃肠病学 胃肠病学
- 肺部病理学 肺部病理学
- 流行病学 流行病学
背景情况:
- 患有炎症性肠病 (IBD) 的患者患有细菌性肺炎的风险较高,导致大量的发病率和死亡率.
- 虽然已知IBD患者肺炎的众多风险因素,包括药物和并发症,但IBD的独立作用仍然不确定.
- 这项研究假设,除了IBD本身之外的因素是增加肺炎风险的主要驱动因素.
研究的目的:
- 确定炎症性肠病 (IBD),并存的疾病和药物治疗对发展肺炎的风险的具体贡献.
- 区分IBD对肺炎发病率的影响与其他促成因素的影响.
主要方法:
- 一项回顾性队列研究利用了来自我们所有人研究计划数据库的数据,涵盖了2010-2022年.
- 倾向性得分匹配 (1:1比) 用于将2810名IBD参与者与四个模型中的对照进行比较:人口统计/生活方式,人口统计/生活方式加并发病,人口统计/生活方式加药物,以及所有因素的组合.
- 考克斯的比例危险模型评估了肺炎风险,而后勤回归确定了相关的风险因素.
主要成果:
- 在对5620名匹配参与者的初级分析中,当考虑所有因素时,炎症性肠病 (IBD) 与肺炎风险增加没有独立联系 (HR = 1.07).
- 然而,IBD患者在仅根据人口统计和生活方式进行匹配时,肺炎风险显著增加 (HR=2.08).
- 在IBD队列中,高并发症负担 (查尔森并发症指数≥10) 和全身类固醇使用分别与肺炎风险增加有关 (分别为OR=12.20和OR=2.26).
结论:
- 炎症性肠道疾病 (IBD) 患者的肺炎风险主要是由并发症和全身类固醇使用驱动的,而不是IBD本身.
- 临床管理策略应优先解决这些已识别的风险因素.
- 应强调对IBD患者进行疫苗接种,这些患者被确定为肺炎高风险患者.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
324
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
324
COPD: Pathogenesis and Clinical Features
535
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
535
Pneumonia II: Pathophysiology
603
The pathophysiology of pneumonia involves the following steps:
603
Pneumonia III: Complications and Assessment
453
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
453
Pulmonary Tuberculosis I
332
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
332
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K


